Jan 20, 2008
My family member doctor has suggested that he changes his treatment from Truvada, Valtrex, Zerit and Kaletra that is working well with no side effects to Prezista, Novir, truvada and valtrex do you know of any advantage or disadvantage to such a change.
| Response from Dr. Young
Thanks for your post.
Without knowing your treatment and drug resistance history, it's difficult to make specific recommendations.
The switch from your current regimen to one of Truvada (tenofovir/FTC) with Norvir-boosted Prezista should continue to be potent and indeed, at least as the Kaletra to Prezista switch is concerned, be better tolerated with lower impact on lipids (cholesterol and triglycerides). The biggest part of the new regimen is the elimination of Zerit (d4T), a drug which hardly ever sees new prescriptions in this country because of excess risk of lipoatrophy, peripheral neuropathy and pancreatitis. The total number of pills and prescriptions remains the same.
I hope this helps, let us know how the new regimen works for you. BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Vaginal Discharge After Unprotected Anal Sex Without Ejaculation Does It Mean I Have HIV
- After Being Exposed To Hpv How Long Does It Take For Signs Of Cervical Cancer To Appear
- Can Two People Who've Never Had Sex Get Std?
- The Clap Std
- What Would Cause Vaginal Bleeding All Of A Sudden?
- Are Lymph Node Swelling Ringing Ears Vision Change Signs Of Hiv?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.